SARS-CoV-2 (COVID-19) Antigen Test (Lateral Flow Assay)
2Pages

SARS-CoV-2 (COVID-19) Antigen Test (Lateral Flow Assay) Early detection of COVID-19-quick inform of infection status Direct detection of virus with sample type of nasopharyngeal or oropharyngeal swab Easy to use, no equipment required: visual interpretation of results Instant result in 15 mins Specificity: 100%; Sensitivity: 89.1% Clinical Value & Principle This rapid test is used for the in vitro detection of SARS-COV-2 antigen through human nasopharyngeal or oropharyngeal swabs. A quick diagnosis will allow medical staff to treat patient and to control the pandemic more efficiently and expediently. This test is an Lateral Flow Assay-based application. The colored line reveal the presence of the antigen. The antigen is generally detectable in the samples of the upper respiratory tracts when the acute stage of infection is present. Application Period of Different COVID-19 Testing Methods SARS-CoV-2 PCR Test SARS-CoV-2 Antigen Test SARS-CoV-2 lgG / IgM Test Day(s) since infection Wuxi BioHermes Bio & Medical Technology Co., Ltd. E-mail: info@biohermes.com.cn

Test Procedure Marked line Extraction buffer Transfer 300 μL (draw to marked line) of extraction buffer Insert the swab and rotate more than 5 times Squeeze the tube bottom (along with swab tip) several times Squeeze the swab tip again before removal Cover the dripper tightly onto the tube Add 80 μL(about 3-4 drops) processed specimen to the sample well Product Information Product SARS-CoV-2 Antigen Test (Lateral Flow Assay) Sample Type Nasopharyngeal/orophary ngeal swab Wuxi BioHermes Bio & Medical Technology Co., Ltd. No.136 Mashan Meiliang Road, Binhu, Wuxi, Jiangsu 214092, China Tel: +...